The obesity summit brings together international scientists to discuss and debate the main research, clinical and psychosocial factors of obesity, its treatment and causes.
Dr Stuart Flint (Sheffield Hallam University) will discuss the increasing evidence that weight stigma is reported (but often goes unchallenged) in the UK by people of all backgrounds and in a range of settings including workplaces and schools. People may be discriminated against in the workplace based on weight and this may be due to sources in society that influence public attitudes towards weight status. While Ms Lesley Gray (University of Otago, New Zealand) will present on three connected research projects being undertaken around training for health professionals and the awkwardness around the language about obesity.
Professor Timothy Frayling (Royal Devon & Exeter NHS Foundation Trust and University of Exeter) will discuss the genetic component to obesity – an often controversial subject which current research shows that biological factors including genes play an important role in influencing where you are on the BMI scale. Even more striking is that these factors are just as strong if not stronger in today’s modern obesogenic environment. Dr Deborah Kurrash’s (University of Calgary, Canada) work points to a potential mechanism as to how maternal obesity might be translated into developmental changes in the fetal brain.
Professor Fary Cachelin’s talk (University of North Carolina at Charlotte. USA) will discuss binge eating and obesity (which are prevalent) in the U.S. Latinas and other ethnic groups but can be treated with existing treatments that are culturally adapted, while Dr Ellen Govers’ talk (VU University, Amsterdam) will focus on insulin resistance in prevention and management of obesity.
Dr Philipp Nett (Bern University Hospital and University of Bern, Switzerland) will talk about weight regain after biliopancreatic diversion with duodenal switch (BPD-DS). Re-sleeve gastrectomy (re-SG) is proofed to be a feasible and safe option to increase weight loss in patients with significant weight regain after BPD-DS
For more information please go to www.obesity2016.com